Načítá se...
A brief introduction to China's new Drug Administration Law and its impact on medications for rare diseases
The Drug Administration Law of the People's Republic of China (amended in August 2019) is a major piece of legislation governing drug administration in China. This law seeks to improve health legislation; to achieve this, it defines the concepts of fake drugs and inferior drugs and their differ...
Uloženo v:
| Vydáno v: | Intractable Rare Dis Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
International Research and Cooperation Association for Bio & Socio-Sciences Advancement
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6929591/ https://ncbi.nlm.nih.gov/pubmed/31890448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2019.01133 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|